Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Hepatology. 2010 Sep;52(3):945–953. doi: 10.1002/hep.23748

Fig. 3.

Fig. 3

Confirmation of EMT in P2 tumors. (A) Immunofluorescent staining for E-cadherin confirms the mesenchymal phenotype of P2M cells. (B) Representative hematoxylin-eosin staining and immunohistochemical staining with E-cadherin in P2 tumor with mixed epithelial and mesenchymal morphology.